The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the ...
Breast cancer is hard enough. Treatment should be quick and easy. That's the thinking of many physicians who have opted to offer MammoSite, a type of radiation that cuts treatment time from several ...
NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, today ...
A breast cancer diagnosis usually brings up many feelings at once. Getting the facts you need to choose the best treatment plan can help you feel more in control. If surgery is an option for you, one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results